Contact
searchSearch
HMP Global

January 2014 - FRMC

Evaluation of Errors When Using e-Prescribing
01/21/2014
Kerri Fitzgerald
San Antonio—While electronic prescribing (e-prescribing) has been widely recommended for its ability to reduce medication errors, especially transcription errors; however, according to recent study literature, the rates of e-prescribing...
San Antonio—While electronic prescribing (e-prescribing) has been widely recommended for its ability to reduce medication errors, especially transcription errors; however, according to recent study literature, the rates of e-prescribing...
San Antonio—While electronic...
01/21/2014
First Report Managed Care
Conference Insider
Low Adherence Rates for Patients with Severe Hemophilia
01/21/2014
Kerri Fitzgerald
San Antonio—Prophylaxis with factor VII or IX has been shown to reduce bleeding episodes for patients with hemophilia A and B; however, a recent study finds that most individuals with severe hemophilia are not adherent to a routine...
San Antonio—Prophylaxis with factor VII or IX has been shown to reduce bleeding episodes for patients with hemophilia A and B; however, a recent study finds that most individuals with severe hemophilia are not adherent to a routine...
San Antonio—Prophylaxis with...
01/21/2014
First Report Managed Care
Alternative Distribution Strategies: “Buy and Bill” and “White Bagging”
01/21/2014
Tim Casey
When handling specialty drugs, physicians typically purchase the medications directly from distributors, administer them to patients, and then bill payers.
When handling specialty drugs, physicians typically purchase the medications directly from distributors, administer them to patients, and then bill payers.
When handling specialty drugs,...
01/21/2014
First Report Managed Care
Stenting Added to Medical Therapy for Atherosclerotic Renal Artery Stenosis
01/21/2014
Tim Casey
Dallas—Stenting added to medical therapy did not reduce the rate of major cardiovascular and renal events compared with medical therapy alone in patients with atherosclerotic renal artery stenosis and hypertension or chronic kidney disease,...
Dallas—Stenting added to medical therapy did not reduce the rate of major cardiovascular and renal events compared with medical therapy alone in patients with atherosclerotic renal artery stenosis and hypertension or chronic kidney disease,...
Dallas—Stenting added to medical...
01/21/2014
First Report Managed Care
Conference Insider
Long-Term Results of Evolocumab to Treat Hypercholesterolemia
01/21/2014
Tim Casey
Dallas—After a year of treatment, patients with hypercholesterolemia who received evolocumab plus the standard of care had a mean reduction of 50% in low-density lipoprotein (LDL) cholesterol compared with a group that took optimal standard...
Dallas—After a year of treatment, patients with hypercholesterolemia who received evolocumab plus the standard of care had a mean reduction of 50% in low-density lipoprotein (LDL) cholesterol compared with a group that took optimal standard...
Dallas—After a year of...
01/21/2014
First Report Managed Care
Edoxaban Versus Warfarin for Patients with AF
01/21/2014
Tim Casey
Dallas—A randomized, double-blind trial that included patients with atrial fibrillation (AF) found that 2, once-daily doses of edoxaban were noninferior to warfarin in preventing strokes or systemic embolic events. Patients who received...
Dallas—A randomized, double-blind trial that included patients with atrial fibrillation (AF) found that 2, once-daily doses of edoxaban were noninferior to warfarin in preventing strokes or systemic embolic events. Patients who received...
Dallas—A randomized,...
01/21/2014
First Report Managed Care
Combination of Treatment for PAD Yielded Better Results
01/21/2014
Tim Casey
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral arterial disease (PAD) and intermittent claudication who underwent endovascular revascularization and supervised exercise therapy had a significant improvement in walking distance and quality of life compared...
Dallas—Patients with peripheral...
01/21/2014
First Report Managed Care
High Frequency Source Ablation Similar to Standard Treatment for AF
01/21/2014
Tim Casey
Dallas—A prospective, multi-center, single-blind, randomized trial found that patients with paroxysmal, symptomatic, drug-refractory atrial fibrillation (AF) had no significant difference in freedom from AF or atrial tachyarrhythmias after 1...
Dallas—A prospective, multi-center, single-blind, randomized trial found that patients with paroxysmal, symptomatic, drug-refractory atrial fibrillation (AF) had no significant difference in freedom from AF or atrial tachyarrhythmias after 1...
Dallas—A prospective,...
01/21/2014
First Report Managed Care
CATIS Trial on Blood Pressure Reduction
01/21/2014
Kerri Fitzgerald
Dallas—Previous clinical trials have found that lowering blood pressure (BP) reduces the risk of stroke in hypertensive and normotensive patients with a history of stroke or transient ischemic attack. However, the effect of antihypertensive...
Dallas—Previous clinical trials have found that lowering blood pressure (BP) reduces the risk of stroke in hypertensive and normotensive patients with a history of stroke or transient ischemic attack. However, the effect of antihypertensive...
Dallas—Previous clinical trials...
01/21/2014
First Report Managed Care
Ibrutinib to Treat CLL/SLL
01/21/2014
Tim Casey
New Orleans—After at least a year of treatment with ibrutinib, more than 80% of patients with treatment-naïve or relapsed/refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) had a partial or complete response,...
New Orleans—After at least a year of treatment with ibrutinib, more than 80% of patients with treatment-naïve or relapsed/refractory chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) had a partial or complete response,...
New Orleans—After at least a...
01/21/2014
First Report Managed Care
Conference Insider
GMI-1070 to Treat Sickle Cell Disease
01/21/2014
Tim Casey
New Orleans—Patients with sickle cell disease who received GMI-1070 after hospitalization had faster vaso-occlusive crisis (VOC) resolution and a shorter length of hospital stay compared with a group taking placebo, according to a randomized,...
New Orleans—Patients with sickle cell disease who received GMI-1070 after hospitalization had faster vaso-occlusive crisis (VOC) resolution and a shorter length of hospital stay compared with a group taking placebo, according to a randomized,...
New Orleans—Patients with sickle...
01/21/2014
First Report Managed Care
First Randomized Study of Patients with Multicentric Castleman’s Disease
01/21/2014
Tim Casey
New Orleans—Patients with multicentric Castleman’s disease (MCD) who received siltuximab had a significantly better durable tumor and symptom response and time to treatment failure compared with a placebo group, according to the first...
New Orleans—Patients with multicentric Castleman’s disease (MCD) who received siltuximab had a significantly better durable tumor and symptom response and time to treatment failure compared with a placebo group, according to the first...
New Orleans—Patients with...
01/21/2014
First Report Managed Care
Lenalidomide and Dexamethasone for Multiple Myeloma Patients Superior to Standard of Care Regimen
01/21/2014
Tim Casey
New Orleans—After a median follow-up of 37 months, older patients with newly diagnosed multiple myeloma (MM) had a significant 28% reduction in disease progression or death if they received continuous treatment with lenalidomide plus low-dose...
New Orleans—After a median follow-up of 37 months, older patients with newly diagnosed multiple myeloma (MM) had a significant 28% reduction in disease progression or death if they received continuous treatment with lenalidomide plus low-dose...
New Orleans—After a median...
01/21/2014
First Report Managed Care
Obinutuzumab Superior to Rituximab in Older Patients with CLL
01/21/2014
Tim Casey
New Orleans—In a head-to-head phase 3 trial, older patients with previously untreated chronic lymphocytic leukemia (CLL) and comorbidities had a significant increase in median progression-free survival and a higher response rate if they were...
New Orleans—In a head-to-head phase 3 trial, older patients with previously untreated chronic lymphocytic leukemia (CLL) and comorbidities had a significant increase in median progression-free survival and a higher response rate if they were...
New Orleans—In a head-to-head...
01/21/2014
First Report Managed Care
Bleeding Events in Patients with VTE in a Real World Setting
01/20/2014
Tim Casey
New Orleans—A retrospective observational analysis of a commercial insurance and Medicare database found that among patients with venous thromboembolism (VTE), the annual incidence of major bleeding was 3.9% and the annual incidence of...
New Orleans—A retrospective observational analysis of a commercial insurance and Medicare database found that among patients with venous thromboembolism (VTE), the annual incidence of major bleeding was 3.9% and the annual incidence of...
New Orleans—A retrospective...
01/20/2014
First Report Managed Care
Nonadherence to Statins Impacts Medicare Spending
01/20/2014
Kerri Fitzgerald
Medication nonadherence costs the US healthcare system nearly $300 billion annually. Studies have shown that patients who adhere to medication regimens have fewer hospitalizations, lower costs, and lower mortality when compared with...
Medication nonadherence costs the US healthcare system nearly $300 billion annually. Studies have shown that patients who adhere to medication regimens have fewer hospitalizations, lower costs, and lower mortality when compared with...
Medication nonadherence costs...
01/20/2014
First Report Managed Care
Type of Insurance Affects Emergency Department Wait Time
01/20/2014
Kerri Fitzgerald
As need for emergency services and costs continue to rise, patients at EDs face long waits and medical professionals find themselves weighed down by overcrowding.
As need for emergency services and costs continue to rise, patients at EDs face long waits and medical professionals find themselves weighed down by overcrowding.
As need for emergency services...
01/20/2014
First Report Managed Care
Study Evaluates Cervical Cancer Screening with HPV 16 and 18 Genotyping
01/20/2014
Eileen Koutnik-Fotopoulos
Studies have shown that a majority of cervical cancer incidences are due to infection with the human papillomavirus (HPV). There are 15 types of high-risk HPV that may lead to the development of cervical intraepithelial neoplasia (CIN) and...
Studies have shown that a majority of cervical cancer incidences are due to infection with the human papillomavirus (HPV). There are 15 types of high-risk HPV that may lead to the development of cervical intraepithelial neoplasia (CIN) and...
Studies have shown that a...
01/20/2014
First Report Managed Care
3DCRT Treatment Shows Better Survival for Cervical Cancer
01/20/2014
Eileen Koutnik-Fotopoulos
In the late 1990s, 3-dimensional conformal radiation therapy (3DCRT) emerged as a preferred treatment for gynecologic malignancies because it provided better and more precise target coverage and significantly reduced the volume of...
In the late 1990s, 3-dimensional conformal radiation therapy (3DCRT) emerged as a preferred treatment for gynecologic malignancies because it provided better and more precise target coverage and significantly reduced the volume of...
In the late 1990s, 3-dimensional...
01/20/2014
First Report Managed Care
Weight Reduction Intervention Significantly Reduces Symptoms of AF
01/20/2014
Mary Beth Nierengarten
Results of single-center, partially-blinded, randomized controlled trial show that weight reduction with intensive management of risk factors for atrial fibrillation (AF) reduce the symptoms and severity of AF and benefit cardiac remodeling...
Results of single-center, partially-blinded, randomized controlled trial show that weight reduction with intensive management of risk factors for atrial fibrillation (AF) reduce the symptoms and severity of AF and benefit cardiac remodeling...
Results of single-center,...
01/20/2014
First Report Managed Care
News Connection
Multifaceted Intervention Leads to Improved Cardioprotective Medication Adherence
01/20/2014
Mary Mihalovic
The use of a multifaceted intervention led to improved adherence to cardioprotective medications after hospital discharge for acute coronary syndrome (ACS) by approximately 15%, according to results of a recent study [JAMA Intern Med....
The use of a multifaceted intervention led to improved adherence to cardioprotective medications after hospital discharge for acute coronary syndrome (ACS) by approximately 15%, according to results of a recent study [JAMA Intern Med....
The use of a multifaceted...
01/20/2014
First Report Managed Care
Study Finds Use of CPR Tool Reduces Use of Antibiotics
01/20/2014
Jill Sederstorm
A new randomized clinical trial found that the use of an integrated clinical prediction rule (CPR) tool reduced the use of antibiotics and resulted in less rapid streptococcal tests compared to those providers in the control group. The...
A new randomized clinical trial found that the use of an integrated clinical prediction rule (CPR) tool reduced the use of antibiotics and resulted in less rapid streptococcal tests compared to those providers in the control group. The...
A new randomized clinical trial...
01/20/2014
First Report Managed Care
Obesity Medications Approved for Long-Term Use More Likely to Lead to Weight Loss
01/20/2014
Mary Beth Nierengarten
Results of a systematic literature review of the 7 current FDA-approved medications for the treatment of obesity in adults finds that 3 medications approved for long-term use, when used as an adjunct to lifestyle intervention, lead to a...
Results of a systematic literature review of the 7 current FDA-approved medications for the treatment of obesity in adults finds that 3 medications approved for long-term use, when used as an adjunct to lifestyle intervention, lead to a...
Results of a systematic...
01/20/2014
First Report Managed Care
News Connection
Findings on Dual Antiplatelet Therapy
01/20/2014
Jill Sederstorm
A new noninferiority study examining the duration of dual antiplatelet therapy for patients who received zotarolimus-eluting stents found that 3-months of dual antiplatelet therapy (DAPT) was noninferior to 12 months of therapy when...
A new noninferiority study examining the duration of dual antiplatelet therapy for patients who received zotarolimus-eluting stents found that 3-months of dual antiplatelet therapy (DAPT) was noninferior to 12 months of therapy when...
A new noninferiority study...
01/20/2014
First Report Managed Care
Department
Government Shutdown Will Have Lasting Negative Effects
01/20/2014
Eileen Koutnik-Fotopoulos
The 16-day federal shutdown in October caused US public health and biomedical research systems immediate and long-term problems.
The 16-day federal shutdown in October caused US public health and biomedical research systems immediate and long-term problems.
The 16-day federal shutdown in...
01/20/2014
First Report Managed Care
ASH Releases List of 5 Unnecessary and Potentially Harmful Tests
01/20/2014
Tim Casey
New Orleans—With more attention in healthcare focused on ways to control spending and improve health, industry professionals have spent the past few years reexamining delivery and payment methods and questioning the status quo. In April 2012,...
New Orleans—With more attention in healthcare focused on ways to control spending and improve health, industry professionals have spent the past few years reexamining delivery and payment methods and questioning the status quo. In April 2012,...
New Orleans—With more attention...
01/20/2014
First Report Managed Care
US Healthcare Spending Increases 3.7% to $2.8 Trillion in 2012
01/20/2014
Tim Casey
Since 1960, researchers from the federal government have tracked healthcare spending in the United States. With that data available, economists today can analyze the factors that have led to slowdowns and increases in expenditures. They have...
Since 1960, researchers from the federal government have tracked healthcare spending in the United States. With that data available, economists today can analyze the factors that have led to slowdowns and increases in expenditures. They have...
Since 1960, researchers from the...
01/20/2014
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

Commentary
Next-Generation Utilization Management: Managing Utilization and Cost Without Denial of Service​​​
03/01/2024
Amit Gupta, MD
Utilization management is evolving from a cost-centric process to a focus on quality of care, with trends including exception-based authorization handling and value-based arrangements to reduce administrative burden and provider abrasion.
Utilization management is evolving from a cost-centric process to a focus on quality of care, with trends including exception-based authorization handling and value-based arrangements to reduce administrative burden and provider abrasion.
Utilization management is...
03/01/2024
First Report Managed Care
Shannon Smith Headshot
Commentary
Adapting to Change: Navigating the New CMS Prior Authorization Guidelines in Health Care
04/02/2024

Shannon Smith, RN, BSN

Shannon Smith, RN, BSN
As the health care industry prepares for the Centers for Medicare & Medicaid Services (CMS) to implement new guidelines to streamline prior authorization procedures, significant operational changes are on the horizon for health care payers....
As the health care industry prepares for the Centers for Medicare & Medicaid Services (CMS) to implement new guidelines to streamline prior authorization procedures, significant operational changes are on the horizon for health care payers....
As the health care industry...
04/02/2024
First Report Managed Care
Conference Coverage
Rare Orphan, Oncology, and Specialty Drugs in Development: Review of Therapeutic Areas, Designations, and Launch Projections
05/01/2024
Danielle Sposato
The specialty pharmacy pipeline was the subject of one of many informative sessions at the annual Asembia Summit this year. Key insights were shared about current drugs in the pipeline according to their drug designations, the phase of each...
The specialty pharmacy pipeline was the subject of one of many informative sessions at the annual Asembia Summit this year. Key insights were shared about current drugs in the pipeline according to their drug designations, the phase of each...
The specialty pharmacy pipeline...
05/01/2024
First Report Managed Care
News
Using Mindfulness-Based Intervention to Improve Fatigue, Mood Challenges in Adolescents With Neuroimmune Disease
05/28/2024
Grace Taylor, MS, MA
Study examines the effectiveness of the Learning to BREATHE mindfulness-based intervention in improving fatigue and mood challenges in a adolescent population with neuroimmune disease.
Study examines the effectiveness of the Learning to BREATHE mindfulness-based intervention in improving fatigue and mood challenges in a adolescent population with neuroimmune disease.
Study examines the effectiveness...
05/28/2024
First Report Managed Care
Leyla Henderson
Conference Coverage
Strategies for Enhancing Infusion Patient Experiences
07/10/2024
Leyla Henderson
An NICA 2024 session speaker shares innovative strategies for enhancing patient satisfaction and improving outcomes in health care settings, emphasizing the importance of patient-centered care and individualized experiences.
An NICA 2024 session speaker shares innovative strategies for enhancing patient satisfaction and improving outcomes in health care settings, emphasizing the importance of patient-centered care and individualized experiences.
An NICA 2024 session speaker...
07/10/2024
First Report Managed Care

January 2014 Volume 11 Issue 1

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use